284 related articles for article (PubMed ID: 27208161)
1. A class of their own: exploring the nondeacetylase roles of class IIa HDACs in cardiovascular disease.
Wright LH; Menick DR
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H199-206. PubMed ID: 27208161
[TBL] [Abstract][Full Text] [Related]
2. Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease.
Li P; Ge J; Li H
Nat Rev Cardiol; 2020 Feb; 17(2):96-115. PubMed ID: 31350538
[TBL] [Abstract][Full Text] [Related]
3. Class IIa histone deacetylases: regulating the regulators.
Martin M; Kettmann R; Dequiedt F
Oncogene; 2007 Aug; 26(37):5450-67. PubMed ID: 17694086
[TBL] [Abstract][Full Text] [Related]
4. Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases.
Eom GH; Kook H
Pharmacol Ther; 2014 Aug; 143(2):168-80. PubMed ID: 24594235
[TBL] [Abstract][Full Text] [Related]
5. Targeting Class IIa HDACs: Insights from Phenotypes and Inhibitors.
Liu L; Dong L; Bourguet E; Fairlie DP
Curr Med Chem; 2021; 28(42):8628-8672. PubMed ID: 34212828
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia.
Bai G; Wei D; Zou S; Ren K; Dubner R
Mol Pain; 2010 Sep; 6():51. PubMed ID: 20822541
[TBL] [Abstract][Full Text] [Related]
7. Post-translational modifications talk and crosstalk to class IIa histone deacetylases.
Guttzeit S; Backs J
J Mol Cell Cardiol; 2022 Jan; 162():53-61. PubMed ID: 34416247
[TBL] [Abstract][Full Text] [Related]
8. Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.
Kee HJ; Kook H
J Biomed Biotechnol; 2011; 2011():928326. PubMed ID: 21151616
[TBL] [Abstract][Full Text] [Related]
9. A Fluorescence-Lifetime-Based Binding Assay for Class IIa Histone Deacetylases.
Meyners C; Mertens M; Wessig P; Meyer-Almes FJ
Chemistry; 2017 Mar; 23(13):3107-3116. PubMed ID: 27922200
[TBL] [Abstract][Full Text] [Related]
10. Role of HDACs in normal and malignant hematopoiesis.
Wang P; Wang Z; Liu J
Mol Cancer; 2020 Jan; 19(1):5. PubMed ID: 31910827
[TBL] [Abstract][Full Text] [Related]
11. Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach.
Hsu KC; Liu CY; Lin TE; Hsieh JH; Sung TY; Tseng HJ; Yang JM; Huang WJ
Sci Rep; 2017 Jun; 7(1):3228. PubMed ID: 28607401
[TBL] [Abstract][Full Text] [Related]
12. Zinc-dependent histone deacetylases: Potential therapeutic targets for arterial hypertension.
Kee HJ; Kim I; Jeong MH
Biochem Pharmacol; 2022 Aug; 202():115111. PubMed ID: 35640713
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Class IIa HDACs improves endothelial barrier function in endotoxin-induced acute lung injury.
Kovacs-Kasa A; Kovacs L; Cherian-Shaw M; Patel V; Meadows ML; Fulton DJ; Su Y; Verin AD
J Cell Physiol; 2021 Apr; 236(4):2893-2905. PubMed ID: 32959895
[TBL] [Abstract][Full Text] [Related]
14. Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs).
Luo Y; Li H
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266366
[TBL] [Abstract][Full Text] [Related]
15. Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis.
Clocchiatti A; Florean C; Brancolini C
J Cell Mol Med; 2011 Sep; 15(9):1833-46. PubMed ID: 21435179
[TBL] [Abstract][Full Text] [Related]
16. Aurora B-dependent regulation of class IIa histone deacetylases by mitotic nuclear localization signal phosphorylation.
Guise AJ; Greco TM; Zhang IY; Yu F; Cristea IM
Mol Cell Proteomics; 2012 Nov; 11(11):1220-9. PubMed ID: 22865920
[TBL] [Abstract][Full Text] [Related]
17. Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension.
Lemon DD; Horn TR; Cavasin MA; Jeong MY; Haubold KW; Long CS; Irwin DC; McCune SA; Chung E; Leinwand LA; McKinsey TA
J Mol Cell Cardiol; 2011 Jul; 51(1):41-50. PubMed ID: 21539845
[TBL] [Abstract][Full Text] [Related]
18. Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis.
Zhou B; Margariti A; Zeng L; Xu Q
Cardiovasc Res; 2011 Jun; 90(3):413-20. PubMed ID: 21233251
[TBL] [Abstract][Full Text] [Related]
19. Class IIa HDACs - new insights into their functions in physiology and pathology.
Parra M
FEBS J; 2015 May; 282(9):1736-44. PubMed ID: 25244360
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylases in modulating cardiac disease and their clinical translational and therapeutic implications.
Wang Z; Zhao YT; Zhao TC
Exp Biol Med (Maywood); 2021 Jan; 246(2):213-225. PubMed ID: 32727215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
